An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209886
Company: UPSHER SMITH LABS

Products on ANDA 209886

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209886

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/25/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 209886

BEXAROTENE

CAPSULE;ORAL; 75MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	210105	AMNEAL PHARMS NY
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	209861	ANI PHARMS
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	203174	BIONPHARMA
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	203663	HIKMA
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	209931	TEVA PHARMS USA
BEXAROTENE	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	No	AB	209886	UPSHER SMITH LABS
TARGRETIN	BEXAROTENE	75MG	CAPSULE;ORAL	Prescription	Yes	AB	021055	VALEANT LUXEMBOURG

Top